Effects of OR-1896, an active metabolite of levosimendan, on contractile force and aequorin light transients in intact rabbit ventricular myocardium

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 1, 2000, Pages 118-125

  Takahashi, Reiko ^a   Hassan Talukder, M A ^a   Endoh, Masao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Ca2+ transients; cAMP; Levosimendan; Myofibrillar Ca2+ sensitivity; Positive inotropic effect; Ventricular muscle, rabbit

Indexed keywords

AEQUORIN; CALCIUM; CARBACHOL; CYCLIC AMP; LEVOSIMENDAN; N [4 (1,4,5,6 TETRAHYDRO 4 METHYL 6 OXO 3 PYRIDAZINYL)PHENYL]ACETAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; DRUG STRUCTURE; HEART MUSCLE CONTRACTILE FORCE; INOTROPISM; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 12944316443     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200007000-00016     Document Type: Article

References (7)

1. Farah AE, Alousi AA, Schwarz RP Jr. Positive inotropic agents. Annu Rev Pharmacol Toxicol 1984;24:275-328.
2. Baim DS, McDowell AV, Chemiles J, et al. Evaluation of a new bipyridine inotropic agent - milrinone - in patients with severe congestive heart failure. N Engl J Med 1983;309:748-56.
3. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677-83.
4. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research Group. N Engl J Med 1991;325:1468-75.
5. Endoh M. The effects of various drugs on the myocardial inotropic response. Gen Pharmacol 1995;26:1-31.
6. Haikala H, Linden IB. Mechanisms of action of calcium-sensitizing drugs. J Cardiovasc Pharmacol 1995;26:S10-9.
7. Végh A, Papp JG, Udvary E, Kaszala K. Hemodynamic effects of calcium-sensitizing agents. J Cardiovasc Pharmacol 1995;26: S20-31.